BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 12061483)

  • 1. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Economic and socio-behavioural issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research].
    Moatti JP; Spire B
    Med Sci (Paris); 2003; 19(8-9):878-84. PubMed ID: 14593621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.
    Duran S; Spire B; Raffi F; Walter V; Bouhour D; Journot V; Cailleton V; Leport C; Moatti JP;
    HIV Clin Trials; 2001; 2(1):38-45. PubMed ID: 11590513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAART adherence in culturally diverse patients with HIV/AIDS: a study of male patients from a Veteran's Administration Hospital in northern California.
    Kemppainen JK; Levine RE; Mistal M; Schmidgall D
    AIDS Patient Care STDS; 2001 Mar; 15(3):117-27. PubMed ID: 11313024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users.
    Carrieri MP; Chesney MA; Spire B; Loundou A; Sobel A; Lepeu G; Moatti JP;
    Int J Behav Med; 2003; 10(1):1-14. PubMed ID: 12581944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study.
    Sidat M; Fairley C; Grierson J
    AIDS Patient Care STDS; 2007 Jul; 21(7):509-20. PubMed ID: 17651032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationship.
    Lamiraud K; Moatti JP; Raffi F; Carrieri MP; Protopopescu C; Michelet C; Schneider L; Collin F; Leport C; Spire B
    Med Care; 2012 May; 50(5):410-8. PubMed ID: 22362167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A review of socio-behavioural studies on adherence to antiretroviral treatments: beyond biomedical models?].
    Moatti JP; Spire B; Duran S
    Rev Epidemiol Sante Publique; 2000 Apr; 48(2):182-97. PubMed ID: 10804427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.
    Samet JH; Horton NJ; Meli S; Freedberg KA; Palepu A
    Alcohol Clin Exp Res; 2004 Apr; 28(4):572-7. PubMed ID: 15100608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Côte d'Ivoire.
    Eholié SP; Tanon A; Polneau S; Ouiminga M; Djadji A; Kangah-Koffi C; Diakité N; Anglaret X; Kakou A; Bissagnené E
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):355-8. PubMed ID: 17438479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART.
    Guaraldi G; Murri R; Orlando G; Orlandi E; Sterrantino G; Borderi M; Grosso C; Cattelan AM; Nardini G; Beghetto B; Antinori A; Esposito R; Wu AW
    HIV Clin Trials; 2003; 4(2):99-106. PubMed ID: 12671777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.